# A Study of Gilteritinib in Adults With Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC)

> clinical trial · VERIFIED · 2026-06-26

Status: RECRUITING · Sponsor: Astellas Pharma Global Development, Inc. · Condition: Non-small Cell Lung Cancer (NSCLC)

- Company: Astellas Pharma Global Development, Inc.
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT07140016

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.